New ruthenium(II)-letrozole complexes as anticancer therapeutics.
about
Synthesis and anticancer activity of carbosilane metallodendrimers based on arene ruthenium(ii) complexesIn vitro and in vivo evaluation of water-soluble iminophosphorane ruthenium(II) compounds. A potential chemotherapeutic agent for triple negative breast cancerWater-soluble oxoglaucine-Y(III), Dy(III) complexes: in vitro and in vivo anticancer activities by triggering DNA damage, leading to S phase arrest and apoptosis.Effect of the piperazine unit and metal-binding site position on the solubility and anti-proliferative activity of ruthenium(II)- and osmium(II)- arene complexes of isomeric indolo[3,2-c]quinoline-piperazine hybrids.Investigation of aromatase inhibitory activity of metal complexes of 8-hydroxyquinoline and uracil derivatives.Nitro/nitrosyl-ruthenium complexes are potent and selective anti-Trypanosoma cruzi agents causing autophagy and necrotic parasite deathAntiproliferative effects of copper(II)-polypyridyl complexes in breast cancer cells through inducing apoptosis.Organometallic Iridium(III) anticancer complexes with new mechanisms of action: NCI-60 screening, mitochondrial targeting, and apoptosis.Investigating the therapeutic role and molecular biology of curcumin as a treatment for glioblastomaDinuclear [{(p-cym)RuCl}2(μ-phpy)](PF6)2 and heterodinuclear [(ppy)2Ir(μ-phpy)Ru(p-cym)Cl](PF6)2 complexes: synthesis, structure and anticancer activity.Mixed-ligand ruthenium polypyridyl complexes as apoptosis inducers in cancer cells, the cellular translocation and the important role of ROS-mediated signaling.Analysis of the cytotoxic effects of ruthenium-ketoconazole and ruthenium-clotrimazole complexes on cancer cells.Lipid-based carriers for controlled delivery of nitric oxide.The development of anticancer ruthenium(ii) complexes: from single molecule compounds to nanomaterials.New dinuclear ruthenium arene complexes containing thiosemicarbazone ligands: synthesis, structure and cytotoxic studies.Tuning the cytotoxicity of ruthenium(ii) para-cymene complexes by mono-substitution at a triphenylphosphine/phenoxydiphenylphosphine ligand.DMSO-mediated ligand dissociation: renaissance for biological activity of N-heterocyclic-[Ru(η6-arene)Cl2] drug candidates.Cytotoxicity in vitro, cellular uptake, localization and apoptotic mechanism studies induced by ruthenium(II) complex.A general strategy to add diversity to ruthenium arene complexes with bioactive organic compounds via a coordinated (4-hydroxyphenyl)diphenylphosphine ligand.Transition metal complexes with bioactive ligands: mechanisms for selective ligand release and applications for drug delivery.Supramolecular metalloglycodendrimers selectively modulate lectin binding and delivery of Ru(ii) complexes into mammalian cells.Transfer Hydrogenation and Antiproliferative Activity of Tethered Half-Sandwich Organoruthenium Catalysts.Ruthenium arene complexes with triphenylphosphane ligands: cytotoxicity towards pancreatic cancer cells, interaction with model proteins, and effect of ethacrynic acid substitution
P2860
Q30358389-FB1A600B-229F-44AE-9D0B-2EF7FF3505C2Q30398565-FE168CA0-1ABF-4FCC-86E8-5CB10DF3999FQ30959736-BC70429F-AF6F-4A6E-A7B2-1327B374810CQ33864513-9CC0BDE1-088E-4523-9EBD-9937CAB304EEQ34074415-C30F78A8-26B2-44D2-BB20-6F3DBB82249CQ34299137-68B17A09-B895-42AE-AE92-6DA42B29098DQ35559621-B1905969-A3F2-4CEA-B132-C6FC8E134F79Q36952837-DDDF4E1B-B408-4724-B109-307F80089BECQ38915880-B284CE28-48A5-429E-955C-423AA87F0D47Q38962540-799514E6-B74B-4629-9626-381C7B6B35FBQ38969205-21F14EE1-1AFA-45A0-883C-572CD85EE42FQ39055996-A488BC1F-A139-4027-B897-E7C49CF5D178Q39100762-8D22AF9E-EA14-479B-B749-2C25341FE62EQ39400527-4DD9EF8B-01E1-44C0-886D-9D92D3FA7CEFQ44868326-CA7A904B-16C9-4A1D-8CA2-61AC61ED8F14Q46256422-EDAB3D50-9195-4031-B776-FF778B9FA0A8Q46943389-57ACB62C-A487-4740-A4D1-09A07963F892Q47272198-4B034EFE-EF79-4CB2-9204-2FFE79F83445Q48259223-B5519887-9505-4224-8178-8A86FE0D2BF5Q50803523-F36BFA9B-ADED-4A82-AC02-0CEB6362683EQ51420976-929B45BA-DF5E-489B-BC65-B2ED2FC4BED7Q54978767-FEE4A409-0E72-4DCF-8288-C45782C8E7B4Q58856038-7ECA9E15-B6DE-46E9-AB6B-41489D8698C8
P2860
New ruthenium(II)-letrozole complexes as anticancer therapeutics.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
New ruthenium
@nl
New ruthenium(II)-letrozole complexes as anticancer therapeutics.
@en
type
label
New ruthenium
@nl
New ruthenium(II)-letrozole complexes as anticancer therapeutics.
@en
prefLabel
New ruthenium
@nl
New ruthenium(II)-letrozole complexes as anticancer therapeutics.
@en
P2093
P356
P1476
New ruthenium(II)-letrozole complexes as anticancer therapeutics.
@en
P2093
Cédric Doucet
Dusica Maysinger
Michal Juhas
P304
P356
10.1021/JM301103Y
P407
P577
2012-10-04T00:00:00Z